Biodefense Policy Analysis-A Systems-based Approach.

Health Secur

Diane DiEuliis, PhD, is Senior Research Fellow, National Defense University, Fort Lesley J. McNair, Washington, DC. Venkat Rao, PhD, is Program Director, Health Market, Parsons Government Services, Washington, DC. Emily A. Billings, PhD, is Senior Analyst; Corey B. Meyer, PhD, is a Scientist; and Kavita Berger, PhD, is Principal Scientist; all at Gryphon Scientific, LLC, Takoma Park, MD.

Published: August 2019

Understanding the overall biosecurity and biodefense policy landscape, the relationships between policies and their effects on each other, and the mechanisms for leveraging advances in science and technology to enhance defensive capabilities is crucial for ensuring that policy strategies address long-standing gaps and challenges. To date, policy analyses have been conducted primarily on single issues, which limits analyses of broader effects of policies, particularly after implementation. Here we describe the first-ever systems-based analysis of the US biosecurity and biodefense policy landscape to analyze functional relationships between policies, including examination of the unintended positive or negative consequences of policy actions. This analysis revealed a striking bifurcation of the US policy landscape for countering biological threats, with one grouping of policies focused on prevention of theft, diversion, or deliberate malicious use of biological sciences knowledge, skills, materials, and technologies (ie, biosecurity) and a second grouping on development of capabilities and knowledge to assess, detect, monitor, respond to, and attribute biological threats (ie, biodefense). An analysis of indirect effects demonstrated that policies within groups may result in mutual benefit, but policies in different groups may counteract each other, limiting achievement of the policy objectives in either group. The current policy landscape predominantly focuses on pathogens and toxins, having limited focus on rapidly changing biotechnologies with potential to positively contribute to biodefense capabilities or introduce unknown and/or unacceptable security risk. Based on our analyses, we present actions for implementing biosecurity and biodefense policy in the United States that intends to harness the benefits of science and technology while also minimizing potential risks. This article synthesizes and highlights the major findings and conclusions from the detailed analyses, which can be found in the full report ( http://www.gryphonscientific.com/biosecurity-policy/ ).

Download full-text PDF

Source
http://dx.doi.org/10.1089/hs.2018.0082DOI Listing

Publication Analysis

Top Keywords

biodefense policy
16
policy landscape
16
biosecurity biodefense
12
policy
9
relationships policies
8
science technology
8
biological threats
8
policies groups
8
biodefense
6
policies
6

Similar Publications

Chikungunya fever virus (CHIKV) is a mosquito-borne alphavirus that causes wide-spread human infections and epidemics in Asia, Africa and recently, in the Americas. CHIKV is considered a priority pathogen by CEPI and WHO. Despite recent approval of a live-attenuated CHIKV vaccine, development of additional vaccines is warranted due to the worldwide outbreaks of CHIKV.

View Article and Find Full Text PDF

Introduction to the Special Feature, Part 2: Enabling and Implementing Threat Agnostic Approaches to Biodefense and Public Health.

Health Secur

April 2024

Kelsey Lane Warmbrod, MS, MPH, was a Research Analyst, Global Security, Technology and Policy Group, Pacific Northwest National Laboratory, Richland, WA.

View Article and Find Full Text PDF

Tools and methods of precision medicine are developing rapidly, through both iterative discoveries enabled by innovations in biomedical research (e.g., genome editing, synthetic biology, bioengineered devices).

View Article and Find Full Text PDF

In the wake of the COVID-19 pandemic, the United States is actively reshaping parts of its national security enterprise. This article explores the underlying politics, with a specific interest in the context of biosecurity, biodefense, and bioterrorism strategy, programs, and response, as the United States responds to the most significant outbreak of an emerging infectious disease in over a century. How the implicit or tacit failure to recognize the political will and political decision-making connected to warfare and conflict for biological weapons programs in these trends is explored.

View Article and Find Full Text PDF

Want AI Summaries of new PubMed Abstracts delivered to your In-box?

Enter search terms and have AI summaries delivered each week - change queries or unsubscribe any time!